Semaglutide Reduces 10-Year Risk for T2D in Obese Persons
Sustained treatment with semaglutide needed to maintain reduction in risk for type 2 diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Sustained treatment with semaglutide needed to maintain reduction in risk for type 2 diabetes
Only registered members have full access to PracticeUpdate content.